{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/b2e7d39a09d74e7c88b67147778a8c8a\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/b2e7d39a09d74e7c88b67147778a8c8a-f2dd060a3f0e42e8.gif","duration":2361.2,"title":"Antibiotic Efficacy Against Lyme. Monica Embers PhD. Lyme Aware Delaware Conference. 05.17.24","description":"In this presentation, I discussed the challenges of treating Lyme disease, particularly the persistence of the Borrelia spirochetes after conventional antibiotic treatment. It’s estimated that over 2 million people in the U.S. suffer from post-treatment Lyme disease, characterized by symptoms like pain, cognitive impairment, and fatigue. I highlighted the importance of distinguishing antibiotic tolerance from resistance and shared findings from animal models and human autopsy specimens that indicate spirochetes can remain viable but non-culturable after treatment. I believe that exploring combination therapy could be a promising direction for more effective treatment, and I encourage further research in this area. Thank you for your attention, and I look forward to any questions you may have."}